Partner Headlines - GEVA

  1. Wedbush Securities Sees Preparations Continuing For Expected ...

    Benzinga
  2. Synageva BioPharma Announces Dosing Of Patients Commenced With ...

    Benzinga
  3. Clear Channel Outdoor, Oasis Petroleum And Other Insiders Have ...

    Benzinga
  4. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  5. 4 More Biotech Secondaries Investors Are Watching

    Benzinga
  6. Benzinga's Volume Movers

    Benzinga
  7. 4 Biotech Secondary Offerings Traders Are Watching

    Benzinga
  8. Synageva BioPharma Completes Rolling Submission Of Biologics ...

    Benzinga
  9. Synageva BioPharma Presents Sebelipase Alfa Data At The NASPGHAN ...

    Benzinga
  10. Synageva Shares Tumble Amid Positive Phase 3 Data, A Director's ...

    Benzinga
  11. Acuity Brands Drops On Downbeat Results; GoPro Shares Surge

    Benzinga
  12. Mid-Day Market Update: Acuity Brands Drops On Downbeat Results; ...

    Benzinga
  13. Markets Surge; GM June Sales Rise 1%

    Benzinga
  14. Morning Market Losers

    Benzinga
  15. SYNAGEVA BIOPHARMA

    IBD
  16. Synageva BioPharma Reports Phase 3 Study Meets Primary Endpoint ...

    Benzinga
  17. UPDATE: Morgan Stanley Reiterates on Synageva BioPharma as Brain-Blood ...

    Benzinga
  18. UPDATE: Synageva Biopharma™ Announces 2M Share Proposed Public ...

    Benzinga
  19. Synageva BioPharma Completes Target Enrollment in Phase 3 ARISE ...

    Benzinga
  20. Benzinga's Top Initiations

    Benzinga
  21. UPDATE: Goldman Sachs initiates on Synageva Following Positive ...

    Benzinga
  22. UPDATE: Leerink Swann Downgrades Synageva BioPharma Corp. on ...

    Benzinga
  23. UPDATE: Wedbush Downgrades Synageva BioPharma on Valuation

    Benzinga
  24. Benzinga's Volume Movers

    Benzinga
  25. Synageva BioPharma Prices 2.75M Share Offering at $56.63/Share

    Benzinga
  26. Synageva BioPharma Corp (GEVA) SVP, CFO Carsten Boess sells 9,927 ...

    GuruFocus
  27. UPDATE: Piper Jaffray Reiterates Neutral Rating, Lowers PT on ...

    Benzinga
  28. Synageva Prices 2.15M Share Public Offering at $47.53/Share

    Benzinga
  29. UPDATE: Piper Jaffray Downgrades Synageva to Neutral on Lack ...

    Benzinga
  30. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells ...

    GuruFocus
  31. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells ...

    GuruFocus
  32. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells ...

    GuruFocus
  33. UPDATE: Wedbush Securities Reiterates Outperform Rating, Raises ...

    Benzinga
  34. Three Biotech Stocks Analysts Are Keen On (ARIA, MACK, GEVA)

    Benzinga
  35. Benzinga's Top Initiations

    Benzinga
  36. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells ...

    GuruFocus
  37. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells ...

    GuruFocus
  38. Three Biotech Stocks Analysts Are Keen On (MDVN, GEVA, OPTR)

    Benzinga
  39. Synageva BioPharma Corp. (GEVA) SVP, CFO Carsten Boess sells ...

    GuruFocus
  40. Merck &, Quest Diagnostics Among Stocks Setting 52-Week Highs ...

    FoxBusiness
  41. Synageva BioPharma, WesBanco Hit 52-week Highs Wednesday

    FoxBusiness
  42. Synageva BioPharma, Deltek Hit 52-week Highs Tuesday

    FoxBusiness
  43. ASML, Wolverine World Wide Included in Stocks Up on High Volume ...

    FoxBusiness
  44. Synageva BioPharma Announces $80 Million Proposed Public Offering ...

    Benzinga
  45. Four Winning Trades Based on Analyst Calls

    Benzinga
  46. CF Industries Holdings, SBA Communications Corporation Included ...

    FoxBusiness
  47. Winning Trades Based on Analyst Ratings for June 25

    Benzinga
  48. Synageva BioPharma Jumps on Canaccord Genuity Initiation

    Benzinga
  49. Quest Software, Pharmacyclics, Other Stocks Hit 52-Week Highs ...

    FoxBusiness
  50. UPDATE: Canaccord Genuity Initiates Synageva BioPharma at BUy, ...

    Benzinga
  51. Synageva BioPharma Corp. (GEVA) President & CEO Sanj K Patel ...

    GuruFocus
  52. Synageva BioPharma Announces Interim Data at 8th Annual Lysosomal ...

    Benzinga
Trading Center